Mauritius vs South-East Asia (WHO region): Hypertension: effective treatment coverage (controlled hypertension)
Mauritius
35.4%
in 2019
South-East Asia (WHO region)
13.3%
in 2019
Mauritius rank
16th
South-East Asia (WHO region) rank
13th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Mauritius
- South-East Asia (WHO region)
How they compare
Mauritius currently reports 35.4% against 13.3% in South-East Asia (WHO region), a difference of 22.1%.
That makes Mauritius's figure about 2.7 times South-East Asia (WHO region)'s.
Across all 30 years both countries report, Mauritius has been ahead every year.
Mauritius ranks 16th and South-East Asia (WHO region) ranks 13th of 193 countries.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.8% | 2.6% | 5.2% | Mauritius |
| 2000s | 11.7% | 5.7% | 6.1% | Mauritius |
| 2010s | 25.6% | 10.7% | 14.9% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Mauritius or South-East Asia (WHO region)?
- Mauritius, at 35.4% against 13.3% in South-East Asia (WHO region) as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Mauritius and South-East Asia (WHO region)?
- 22.1%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and South-East Asia (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do Mauritius and South-East Asia (WHO region) rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Mauritius ranks 16th and South-East Asia (WHO region) ranks 13th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.